AbCellera Biologics Inc. ABCL Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$143.96M+1.7% | -$146.41M+14.7% | -$171.68M-3.6% | -$165.67M+1.3% | -$167.87M-3.1% | ||
| $19.9M+8.2% | $18.39M+20.1% | $15.31M+3.4% | $14.81M+8.0% | $13.71M+10.1% | ||
| $53.02M-5.0% | $55.79M-4.0% | $58.11M-5.3% | $61.38M-5.5% | $64.96M-3.9% | ||
| -$153.26M-16.7% | -$131.3M-25.6% | -$104.55M-29.3% | -$80.84M-3.1% | -$78.4M+27.8% | ||
| $35.97M-15.9% | $42.77M-11.9% | $48.56M-16.5% | $58.15M-10.4% | $64.89M-17.2% | ||
| $54.73M-37.6% | $87.75M+81.6% | $48.32M+211% | $15.53M-84.4% | $99.43M-18.1% | ||
| —— | —— | —— | —— | $15.91M+24.6% | ||
| —— | —— | -$43.48M+22.2% | -$55.88M-257% | $35.69M+55.2% | ||
| -$189.23M-8.7% | -$174.07M-13.7% | -$153.11M-10.2% | -$138.99M+3.0% | -$143.29M+23.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does AbCellera Biologics Inc.'s cash flow data come from?
- Every line is extracted from AbCellera Biologics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.